Abpro Signs US$1.75 B Collaboration Deal with Celltrion
By Amit Kaushik
Pharma Deals Review: Vol 2022 Issue 10 (Table of Contents)
Published: 14 Oct-2022
DOI: 10.3833/pdr.v2022.i10.2734 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to boost its pipeline, Abpro has announced a collaboration with Celltrion for the co-development and commercialization of bispecific antibody, ABP-102...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS